Ho-Jin Shin Selected Research

Bone Marrow Transplantation (Transplantation, Bone Marrow)

7/2009	Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
1/2003	Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ho-Jin Shin Research Topics

Disease

25	Multiple Myeloma 12/2021 - 12/2009
20	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 12/2008
15	Lymphoma (Lymphomas) 01/2022 - 09/2007
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2007
9	Neoplasms (Cancer) 01/2022 - 01/2010
6	Neutropenia 10/2022 - 05/2012
5	Febrile Neutropenia 10/2022 - 05/2012
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 09/2011
4	Leukemia 01/2022 - 06/2009
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 12/2010
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 01/2009
4	Aplastic Anemia (Anemia, Hypoplastic) 01/2020 - 07/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 01/2015
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 01/2010
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017 - 11/2009
4	Disease Progression 10/2015 - 02/2008
3	Infections 10/2022 - 12/2014
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2022 - 06/2008
3	Pain (Aches) 01/2022 - 07/2019
3	Hemorrhage 01/2021 - 12/2014
3	Philadelphia Chromosome 12/2017 - 01/2003
2	Myalgia 01/2022 - 10/2019
2	Hemophilia A (Haemophilia) 09/2021 - 09/2019
2	Breast Neoplasms (Breast Cancer) 09/2021 - 03/2019
2	idiopathic Aplastic anemia 01/2020 - 10/2013
2	Hodgkin Disease (Hodgkin's Disease) 11/2019 - 12/2013
2	Anemia 11/2019 - 11/2009
2	Fatigue 10/2019 - 07/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 10/2016 - 01/2009
2	Plasmacytoma 04/2015 - 11/2014
1	Thrombocytopenia (Thrombopenia) 07/2022
1	Asthenia 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2021
1	Hemophilia B (Haemophilia B) 01/2021
1	Frailty 01/2021
1	Low Back Pain (Lumbago) 01/2020
1	Neck Pain (Cervicalgia) 01/2020

Drug/Important Bio-Agent (IBA)

16	Rituximab (Mabthera)FDA Link 10/2022 - 12/2008
15	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 06/2008
11	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 06/2008
10	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 06/2008
10	Bortezomib (Velcade)FDA Link 01/2021 - 01/2010
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2010
8	Prednisone (Sone)FDA LinkGeneric 01/2022 - 12/2008
7	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 06/2012
6	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 06/2008
6	Busulfan (Busulfex)FDA Link 01/2022 - 09/2011
6	Thalidomide (Thalomid)FDA Link 01/2021 - 02/2010
5	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 11/2013
5	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2019
5	Imatinib Mesylate (Gleevec)FDA Link 12/2017 - 11/2009
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2015 - 08/2009
4	R-CHOP protocolIBA 10/2022 - 12/2008
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2015 - 01/2009
3	Inosine Triphosphate (ITP)IBA 07/2022 - 06/2008
3	Ferritins (Ferritin)IBA 04/2020 - 12/2009
3	Core Binding Factors (Core-Binding Factor)IBA 05/2019 - 06/2010
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2015 - 01/2007
2	pegfilgrastim (Neulasta)FDA Link 10/2022 - 10/2022
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022 - 12/2019
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 09/2011
2	daratumumabIBA 01/2020 - 12/2018
2	Monoclonal AntibodiesIBA 10/2019 - 12/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019 - 02/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 05/2012
2	thymoglobulin FDA Link 03/2015 - 10/2013
2	Azacitidine (5 Azacytidine)FDA Link 12/2014 - 01/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2013 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 09/2011 - 01/2010
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 10/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	theasinensin AIBA 01/2022
1	RoflumilastIBA 01/2022
1	polatuzumab vedotinIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021
1	AntibodiesIBA 09/2021
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2021
1	Bendamustine Hydrochloride FDA Link 04/2020
1	Proteasome InhibitorsIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	pomalidomideIBA 01/2020
1	SaltsIBA 01/2020

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 10/2022 - 09/2007
20	Therapeutics 01/2021 - 06/2008
19	Stem Cell Transplantation 01/2022 - 01/2009
6	Hematopoietic Stem Cell Transplantation 01/2020 - 04/2004
5	Induction Chemotherapy 01/2016 - 03/2007
3	Transplantation 01/2018 - 01/2009
2	Remission Induction 01/2021 - 06/2009
2	Radiotherapy 03/2019 - 10/2016
2	Cell Transplantation 08/2015 - 09/2011
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2009 - 01/2003
1	Meditation 01/2022
1	Exoskeleton Device 08/2021
1	Induced Hyperthermia (Thermotherapy) 01/2020
1	Mud Therapy (Mud Bath) 01/2020
1	Aftercare (After-Treatment) 01/2020